Title : Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis.

Pub. Date : 2012 Sep

PMID : 22380717






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 ABCB1 C3435T variants had a borderline decrease in cyclophosphamide elimination rate constant (P = 0.0858; 95% CI -0.005, 0.102). Cyclophosphamide ATP binding cassette subfamily B member 1 Homo sapiens
2 The CYP2B6*9 and ABCB1 C3435T polymorphisms alter the pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide in glomerulonephritis. Cyclophosphamide ATP binding cassette subfamily B member 1 Homo sapiens